News from paragon bioteck, inc

Jun 25, 2014, 16:29 ET

Paragon BioTeck, Inc. Receives FDA Clearance for Comfortear Lacrisolve Absorbable Punctum Plug

 Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic...

Jun 04, 2014, 12:28 ET

Paragon BioTeck announces FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available

Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies,...

Apr 09, 2014, 08:00 ET

Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent Readily Available

 Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies,...

Nov 08, 2013, 18:50 ET

Paragon Puts Ilast® Center Stage

 Leading biopharmaceutical company Paragon BioTeck, Inc. announced today that it plans to launch its new line of products, known as...

Oct 09, 2013, 13:59 ET

Paragon BioTeck Signs Exclusive Distribution Agreement with Horus Pharma for Ilast®

Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast® range of...

Apr 19, 2013, 20:11 ET

Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine

 Bausch + Lomb, the global eye health company and Paragon BioTeck, Inc. today announced that the companies have entered into a license...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge